British American Tobacco (BTI) slides as investors focus on slower 2026 growth outlook

British American Tobacco p.l.c. (BTI) is down 4.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be renewed investor concern around the company’s 2026 outlook, which management has framed as tracking toward the lower end of its medium-term growth targets. Even with ongoing capital returns (dividends and buybacks), a “lower-end” growth narrative can pressure the stock when sentiment shifts risk-off.

Details:

In its full-year results materials and outlook commentary, the company indicated 2026 performance is expected at the lower end of its targeted ranges, with profit delivery described as second-half weighted.

The company highlighted continued investment needs in “New Categories” (non-combustibles), which can create near-term margin sensitivity even if long-term strategy remains intact.

The company also reiterated shareholder-return plans, including an expanded share buyback program for 2026, but the market reaction suggests guidance tone outweighed the capital-return support.

This could also be amplified by broader regulatory and enforcement uncertainty around nicotine/vapor markets, which often raises discount rates for tobacco cash flows during volatile sessions.

Sources:

British American Tobacco (press release), Yahoo Finance, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$BTI Hedge Fund Activity

We have seen 420 institutional investors add shares of $BTI stock to their portfolio, and 371 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

FMR LLC added 10,675,400 shares (+52.3%) to their portfolio in Q4 2025, for an estimated $604,441,148
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,567,053 shares (-98.9%) from their portfolio in Q4 2025, for an estimated $201,966,540
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 2,035,559 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $115,253,350
POINT72 ASSET MANAGEMENT, L.P. removed 1,419,600 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $80,377,752
TRIVEST ADVISORS LTD removed 1,270,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $67,411,600
MARSHALL WACE, LLP added 906,850 shares (+266.9%) to their portfolio in Q4 2025, for an estimated $51,345,847
CITADEL ADVISORS LLC added 798,493 shares (+58.3%) to their portfolio in Q4 2025, for an estimated $45,210,673

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$BTI Congressional Stock Trading

Members of Congress have traded $BTI stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $BTI stock by members of Congress over the last 6 months:

REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 09/25.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$BTI Analyst Ratings

Wall Street analysts have issued reports on $BTI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Argus Research issued a "Buy" rating on 09/08/2025

To track analyst ratings and price targets for $BTI, check out Quiver Quantitative's $BTI forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.